Olema Pharmaceuticals, Inc. OLMA Debt issuance costs and discount amortization
Debt issuance costs and discount amortization at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.
The official record: Olema Pharmaceuticals, Inc.’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s debt issuance costs and discount amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s debt issuance costs and discount amortization?
- Olema Pharmaceuticals, Inc. (OLMA) reported debt issuance costs and discount amortization of -$1.57M in Q4 2025.
- How has Olema Pharmaceuticals, Inc.'s debt issuance costs and discount amortization changed year-over-year?
- Olema Pharmaceuticals, Inc.'s debt issuance costs and discount amortization increased by 23.0% year-over-year, from -$2.04M to -$1.57M.
- What does debt issuance costs and discount amortization mean?
- This represents the non-cash periodic allocation of debt issuance costs and original issue discounts over the life of a debt instrument. It effectively adjusts the reported interest expense to reflect the true effective interest rate of the company's borrowings. Investors monitor this to understand non-cash impacts on net income and cash flow from operations.